Paper40898705
A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.
Geurtsen J and 18 others. Epidemiol Infect, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals. Papers, record 40898705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40898705
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli Infections | Major topic |
| Escherichia coli | Major topic |
| O Antigens | Major topic |
| Humans | |
| Retrospective Studies | |
| Middle Aged | |
| Male | |
| Female | |
| Tertiary Care Centers | |
| Aged | |
| Prevalence | |
| Serogroup | |
| Adult | |
| Aged, 80 and over | |
| Young Adult | |
| Adolescent |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Janssen Research and Development | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,684,979 | Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/35684979 | PubMed |
| 2 | 39,299,261 | Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. | Lancet | 2024 | https://conductscience.org/library/papers/39299261 | PubMed |
| 3 | 33,411,882 | Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/33411882 | PubMed |
| 4 | 39,001,716 | A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39001716 | PubMed |
| 5 | 31,079,947 | Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/31079947 | PubMed |
| 6 | 38,825,856 | Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges. | Gut Microbes | 2024 | https://conductscience.org/library/papers/38825856 | PubMed |
| 7 | 25,278,570 | Population-based epidemiology and microbiology of community-onset bloodstream infections. | Clin Microbiol Rev | 2014 | https://conductscience.org/library/papers/25278570 | PubMed |
| 8 | 23,039,210 | The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. | Clin Microbiol Infect | 2013 | https://conductscience.org/library/papers/23039210 | PubMed |
| 9 | 334,154 | Serology, chemistry, and genetics of O and K antigens of Escherichia coli. | Bacteriol Rev | 1977 | https://conductscience.org/library/papers/334154 | PubMed |
| 10 | 33,642,161 | O-serotype distribution of Escherichia coli bloodstream infection isolates in critically ill patients in The Netherlands. | Vaccine | 2021 | https://conductscience.org/library/papers/33642161 | PubMed |
| 11 | 32,297,949 | Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/32297949 | PubMed |
| 12 | 35,789,262 | Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/35789262 | PubMed |
| 13 | 36,817,744 | Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals. | Open Forum Infect Dis | 2023 | https://conductscience.org/library/papers/36817744 | PubMed |
| 14 | 38,700,324 | Preclinical validation of an Escherichia coli O-antigen glycoconjugate for the prevention of serotype O1 invasive disease. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38700324 | PubMed |
| 15 | 31,189,557 | Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31189557 | PubMed |
| 16 | 25,613,780 | Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe. | Euro Surveill | 2015 | https://conductscience.org/library/papers/25613780 | PubMed |
| 17 | 25,428,893 | A complete view of the genetic diversity of the Escherichia coli O-antigen biosynthesis gene cluster. | DNA Res | 2015 | https://conductscience.org/library/papers/25428893 | PubMed |
| 18 | 26,824,864 | Comparison of O-Antigen Gene Clusters of All O-Serogroups of Escherichia coli and Proposal for Adopting a New Nomenclature for O-Typing. | PLoS One | 2016 | https://conductscience.org/library/papers/26824864 | PubMed |
| 19 | 26,333,944 | Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field. | J Infect Dis | 2016 | https://conductscience.org/library/papers/26333944 | PubMed |
| 20 | 25,596,031 | Escherichia coli ST131: The quintessential example of an international multiresistant high-risk clone. | Adv Appl Microbiol | 2015 | https://conductscience.org/library/papers/25596031 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,646,707 | Formulation Development of a Multivalent Bioconjugate ExPEC Vaccine Candidate: Linking Early Design to Late-Stage Stability and Manufacturability. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646707 | PubMed |
| 42,627,174 | Development and validation of a high-throughput agglutination assay for O-serogrouping clinical Escherichia coli isolates. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42627174 | PubMed |
| 41,872,483 | Molecular epidemiology and structural diversity of O101/O162 O-antigen variants among Escherichia coli bacteremia isolates. | Sci Rep | 2026 | https://conductscience.org/library/papers/41872483 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40898705
GET https://conductscience.org/api/papers/v1/40898705/references?page=2